Table 3 Characteristics of ESRD patients treated by dialysis or living with a renal transplant in the PACA region on December 31 of each year between 2004 and 2015

 All ESRD

4433

4542

4716

4908

5081

5312

5517

5729

5920

6101

6357

6475

 Living with a renal transplant, n (%)

1361 (30.7)

1406 (31.0)

1500 (31.8)

1599 (32.6)

1713 (33.7)

1802 (33.9)

1918 (34.8)

2032 (35.5)

2116 (35.7)

2237 (36.7)

2349 (37.0)

2456 (37.9)

 On dialysis, n (%)

3072 (69.3)

3136 (69.0)

3216 (68.2)

3309 (67.4)

3368 (66.3)

3510 (66.1)

3599 (65.2)

3697 (64.5)

3804 (64.3)

3864 (63.3)

4008 (63.0)

4019 (62.1)

 Age mean ± SD^b

64.9 ± 15,4

65.0 ± 15,3

65.6 ± 15,0

66.1 ± 14,9

66.9 ± 14,6

67.1 ± 14,7

67.5 ± 15,0

69,4 ± 15,0

69.3 ± 15,2

69.6 ± 14,9

69.8 ± 14,9

70,1 ± 15,1

 <  20 years, %

24 (0.8)

20 (0.6)

11 (0.3)

16 (0.5)

11 (0.3)

13 (0.4)

19 (0.5)

16 (0.4)

20 (0.5)

14 (0.4)

14 (0.3)

24 (0.6)

 ≥ 80 years, %

453 (14.7)

466 (14.9)

481 (15.0)

531 (16.0)

622 (18.5)

672 (19.1)

754 (21.0)

1008 (27.3)

1053 (27.7)

1087 (28.1)

1181 (29.5)

1254 (31.2)

Gender: male, n (%)

1843 (60,0)

1887 (60,2)

1949 (60,6)

2011 (60,8)

2035 (60,4)

2151 (61,3)

2202 (61,2)

2275 (61,5)

2371 (62,3)

2431 (62,9)

2500 (62,4)

2567 (63.9)

Residing outside the PACA region, n (%)

102 (3.3)

102 (3.3)

88 (2.7)

92 (2.8)

91 (2.7)

101 (2.9)

92 (2.6)

89 (2.4)

95 (2.5)

93 (2.4)

101 (2.5)

100 (2.5)

 None, %

753 (24.5)

791 (25.2)

824 (25.6)

889 (26.9)

899 (26.7)

990 (28.2)

980 (27.2)

821 (22.2)

866 (22.8)

874 (22.6)

836 (20.9)

858 (21,3)

 Mean number ± SD

2,3 ± 1,4

2,2 ± 1,3

2,1 ± 1,3

2,1 ± 1,3

2,1 ± 1,3

2,1 ± 1,3

2,2 ± 1,4

2,4 ± 1,4

2,5 ± 1,4

2,5 ± 1,5

2,5 ± 1,5

2,5 ± 1,5

Diabetes

782

837

918

933

1022

1103

1174

1290

1369

1446

1563

1597

 MD = 4.4% (10.6–0.2)

(28.3)

(29.8)

(31.3)

(30.7)

(32.2)

(32.8)

(33.5)

(35.2)

(36.1)

(37.5)

(39.1)

(39.0)

 At least one CVD^d

1514

1485

1504

1530

1632

1685

1814

2235

2312

2335

2488

2559

 MD = 4.7% (10.8–0.4)

(54.8)

(53.1)

(51.3)

(50.6)

(51.6)

(50.3)

(52.2)

(60.9)

(61.1)

(60.6)

(62.4)

(62.7)

Cancer

144

147

163

177

192

199

237

296

322

352

373

408

MD = 4.9% (10.9–0.6)

(5.2)

(5.3)

(5.6)

(5.9)

(6.1)

(6.0)

(6.9)

(8.1)

(8.5)

(9.2)

(9.4)

(10.0)

 Underweight (< 18.5)

104 (8.0)

135 (7.7)

136 (7.1)

139 (6.6)

155 (6.6)

155 (5.8)

169 (5.8)

202 (5.8)

192 (5.4)

193 (5.2)

201 (5.3)

204 (5.2)

 Normal (18.5–24.9)

654 (50.5)

867 (49.8)

915 (47.4)

1030 (48.7)

1144 (48.5)

1298 (48.5)

1444 (49.4)

1657 (47.9)

1675 (46.7)

1644 (44.7)

1623 (42.5)

1666 (42.7)

 Overweight (25.0–29.9)

385 (29.7)

506 (29.0)

590 (30.6)

645 (30.5)

718 (30.4)

818 (30.6)

851 (29.1)

1045 (30.2)

1117 (31.1)

1148 (31.2)

1224 (32.0)

1251 (32.1)

Obese (≥ 30)

11.7

13.4

14.9

14.2

14.5

15.1

15.8

16.0

16.8

18.8

20.2

20.0

 DP^f

149 (4,9)

158 (5,0)

146 (4,5)

140 (4,2)

120 (3,6)

126 (3,6)

136 (3,8)

152 (4,1)

161 (4,2)

173 (4,5)

187 (4,7)

196 (4,9)

 HD^g

2923 (95,1)

2978 (95,0)

3070 (95,5)

3169 (95,8)

3248 (96,4)

3384 (96,4)

3463 (96,2)

3545 (95,9)

3643 (95,8)

3691 (95,5)

3821 (95,3)

3913 (97.4)

  In-center HD

2093 (71,6)

2126 (71,4)

2228 (72,6)

2309 (72,9)

2335 (71,9)

2381 (70,4)

2437 (70,4)

2449 (69,1)

2483 (68,2)

2484 (67,3)

2566 (67,2)

2603 (66,5)

  HD in medical satellite unit

1 (0.003)

3 (0,1)

9 (0,3)

39 (1,2)

79 (2,4)

194 (5,7)

314 (9,1)

441 (12,4)

552 (15,2)

625 (16,9)

706 (18,5)

755 (19,3)

  HD in self-care unit

672 (23,0)

745 (25,0)

737 (24,0)

752 (23,7)

779 (24,0)

760 (22,5)

673 (19,4)

619 (17,5)

567 (15,6)

539 (14,6)

522 (13,7)

525 (13,4)

HD at home

157 (5,4)

104 (3,5)

96 (3,1)

69 (2,2)

55 (1,7)

49 (1,4)

39 (1,1)

36 (1,0)

41 (1,1)

43 (1,2)

27 (0,7)

30 (0,8)